Stromová štruktúra MeSH - maytanzín

[d02.540.505.495]

• chemikálie organické [d02] +
  • laktóny [d02.540] +
    • makrolidy [d02.540.505] +
      • amfidinolidy [d02.540.505.113]
      • fidaxomicín [d02.540.505.225]
      • lucenzomycín [d02.540.505.450]
      • maytanzín [d02.540.505.495]
        • trastuzumab emtanzín [d02.540.505.495.500]
      • mepartricín [d02.540.505.497]
      • miokamycín [d02.540.505.500]
      • natamycín [d02.540.505.550]
      • nystatín [d02.540.505.575]
      • oleandomycín [d02.540.505.600] +
      • oligomycíny [d02.540.505.620] +
      • sirolimus [d02.540.505.760] +
      • takrolimus [d02.540.505.810]
      • tylozín [d02.540.505.905]

[d04.345.295.500]

• zlúčeniny polycyklické [d04] +
  • zlúčeniny makrocyklické [d04.345] +
    • laktámy makrocyklické [d04.345.295] +
      • maytanzín [d04.345.295.500]
        • trastuzumab emtanzín [d04.345.295.500.500]
      • rifamycíny [d04.345.295.750] +